Tag: Tissue Management

FDA updates draft guidance on safety of US blood supply

Editor's Note The Food & Drug Administration on December 4 updated a draft guidance that promotes the development and adoption of innovations to ensure continued safety of the US blood supply. The draft guidance entitled, “Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety…

Read More

By: Judy Mathias
December 6, 2018
Share

Restrictive vs liberal transfusion strategy for cardiac surgery patients

Editor's Note In cardiac surgery patients at moderate-to-high risk for death, a restrictive strategy for red blood cell (RBC) transfusion was equivalent to a liberal strategy, with respect to death from any cause, myocardial infarction, stroke, or renal failure, at 6-months follow-up, this study finds. There also were no significant…

Read More

By: Judy Mathias
October 2, 2018
Share

Perioperative RBC transfusions linked to postop VTE

Editor's Note In this study, perioperative red blood cell (RBC) transfusions were significantly associated with development of new or progressive postoperative venous thromboembolism (VTE) within 30 days of a surgical procedure. Of 750,937 patients included in the analysis, 47,410 (6.3%) received at lest one perioperative RBC transfusion. Of these, 6,309…

Read More

By: Judy Mathias
June 18, 2018
Share

Study: Restrictive vs liberal blood transfusion outcomes in cardiac surgery patients

Editor's Note A restrictive blood transfusion strategy (HGB <7.5 g/dL) was equivalent to a liberal strategy (HGB <9.5 g/dL in the OR or ICU and HGB<8.5 g/dL in the non-ICU ward) with regard to mortality and major disability in cardiac surgery patients who had a moderate-to-high risk of death, this…

Read More

By: Judy Mathias
November 16, 2017
Share

Joint Commission updates Patient Blood Management standards

Editor's Note The Joint Commission on November 8 announced the update of its Patient Blood Management standards to align with AABB standards. Among the changes: educational requirements for those who order and/or transfuse blood defined guidelines on transfusion orders procedures for emergent/urgent patients, including massive blood loss intraoperative methods for…

Read More

By: Judy Mathias
November 10, 2017
Share

Effect of organ donor hospital volume on transplantable organs

Editor's Note Hospitals managing the highest volume of deceased organ donors were 52% more likely to recover an above-average number of transplantable organs per donor than low-volume hospitals in this study. The study included data from 4,427 donors across 384 hospitals. High-volume hospitals had an organ yield (ie, rate of…

Read More

By: Judy Mathias
January 19, 2017
Share

FDA issues tissue, cell donation recommendations to reduce Zika virus risk

Editor's Note The Food and Drug Administration (FDA) on March 1 released new guidelines to prevent the transmission of the Zika virus from human cells, tissues, and cellular and tissue-based products. The guidance addresses both living and deceased donations of corneas, bone, skin, heart valves, hematopoietic stem/progenitor cells, gestational tissues…

Read More

By: Judy Mathias
March 3, 2016
Share

Safety, cost savings, simplicity back broader use of bloodless surgery

More than 120 centers throughout the US have bloodless surgery programs to serve patients who refuse blood transfusions for religious and other reasons. The practice, which began more than 50 years ago, has evolved through research on blood conservation and new techniques to minimize the need for transfusions. The Joint…

Read More

By: OR Manager
May 1, 2013
Share

A sound process for acquiring tissue

A surgeon has requested a new tissue graft not in the current inventory. From the company's literature, it's not easy to tell whether the tissue is similar to others already in stock. Decisions like these are challenging because tissue grafts come with a host of safety, clinical, and cost issues.…

Read More

By: Pat Patterson
March 1, 2011
Share

Bone allografts: Options for healing

These are examples of types of bone allograft products and purposes they serve. With the chart on page 12, this information can help OR teams determine where a new allograft product would fit into current inventory. Allograft cancellous chips Cancellous chips, a common nonstructural human allograft bone material, serve as…

Read More

By: OR Manager
March 1, 2011
Share
Live chat by BoldChat